Silo Pharma Book Value Per Share Growth & History (SILO)
Silo Pharma's book value per share was $7.10 for fiscal 2025.
View full Silo Pharma company overviewSilo Pharma annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.10 | -$9.74 | −57.83% |
| 2024 | 2024-12-31 | $16.84 | -$15.04 | −47.18% |
| 2023 | 2023-12-31 | $31.88 | -$17.22 | −35.08% |
| 2022 | 2022-12-31 | $49.10 | -$19.80 | −28.74% |
| 2021 | 2021-12-31 | $68.91 | $57.62 | +510.79% |
| 2020 | 2020-12-31 | $11.28 | $12.01 | — |
| 2019 | 2019-12-31 | -$0.73 | -$13.78 | — |
| 2018 | 2018-12-31 | $13.05 | -$4.97 | −27.57% |
| 2017 | 2017-12-31 | $18.02 | — | — |
| 2013 | 2013-12-31 | $25.65 | $26.66 | — |
| 2012 | 2012-12-31 | -$1.01 | -$0.97 | — |
| 2011 | 2011-12-31 | -$0.04 | — | — |
Silo Pharma quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.33 | -$4.20 | −49.22% |
| Q1 2026 | 2026-03-31 | $5.24 | -$8.18 | −60.95% |
| Q4 2025 | 2025-12-31 | $7.10 | -$9.74 | −57.83% |
| Q3 2025 | 2025-09-30 | $7.18 | -$15.50 | −68.34% |
| Q2 2025 | 2025-06-30 | $8.53 | -$15.49 | −64.50% |
| Q1 2025 | 2025-03-31 | $13.42 | -$14.60 | −52.11% |
| Q4 2024 | 2024-12-31 | $16.84 | -$15.04 | −47.18% |
| Q3 2024 | 2024-09-30 | $22.69 | -$13.49 | −37.28% |
| Q2 2024 | 2024-06-30 | $24.02 | -$16.01 | −39.99% |
| Q1 2024 | 2024-03-31 | $28.02 | -$16.83 | −37.53% |
| Q4 2023 | 2023-12-31 | $31.88 | -$17.22 | −35.08% |
| Q3 2023 | 2023-09-30 | $36.17 | -$20.48 | −36.15% |
| Q2 2023 | 2023-06-30 | $40.03 | -$19.39 | −32.63% |
| Q1 2023 | 2023-03-31 | $44.85 | -$19.32 | −30.11% |
| Q4 2022 | 2022-12-31 | $49.10 | -$19.80 | −28.74% |
| Q3 2022 | 2022-09-30 | $56.65 | -$20.54 | −26.61% |
| Q2 2022 | 2022-06-30 | $59.41 | $30.78 | +107.50% |
| Q1 2022 | 2022-03-31 | $64.16 | $26.92 | +72.28% |
| Q4 2021 | 2021-12-31 | $68.91 | $57.62 | +510.79% |
| Q3 2021 | 2021-09-30 | $77.18 | $58.95 | +323.19% |
| Q2 2021 | 2021-06-30 | $28.63 | $7.85 | +37.75% |
| Q1 2021 | 2021-03-31 | $37.24 | $45.55 | — |
| Q4 2020 | 2020-12-31 | $11.28 | $12.01 | — |
| Q3 2020 | 2020-09-30 | $18.24 | $21.47 | — |
| Q2 2020 | 2020-06-30 | $20.79 | $17.50 | +531.80% |
| Q1 2020 | 2020-03-31 | -$8.31 | -$17.67 | — |
| Q4 2019 | 2019-12-31 | -$0.73 | -$13.78 | — |
| Q3 2019 | 2019-09-30 | -$3.23 | -$18.31 | — |
| Q2 2019 | 2019-06-30 | $3.29 | — | — |
| Q1 2019 | 2019-03-31 | $9.36 | — | — |
| Q4 2018 | 2018-12-31 | $13.05 | -$4.97 | −27.57% |
| Q3 2018 | 2018-09-30 | $15.07 | — | — |
| Q4 2017 | 2017-12-31 | $18.02 | — | — |
| Q4 2013 | 2013-12-31 | $25.65 | $26.66 | — |
| Q3 2013 | 2013-09-30 | $11.25 | $11.96 | — |
| Q2 2013 | 2013-06-30 | $8.14 | $8.64 | — |
| Q1 2013 | 2013-03-31 | -$1.08 | -$0.71 | — |
| Q4 2012 | 2012-12-31 | -$1.01 | -$0.97 | — |
| Q3 2012 | 2012-09-30 | -$0.71 | -$0.82 | — |
| Q2 2012 | 2012-06-30 | -$0.50 | -$1.05 | — |
| Q1 2012 | 2012-03-31 | -$0.36 | — | — |
| Q4 2011 | 2011-12-31 | -$0.04 | -$1.21 | — |
| Q3 2011 | 2011-09-30 | $0.11 | — | — |
| Q2 2011 | 2011-06-30 | $0.55 | — | — |
| As of Dec 31, 2010 | 2010-12-31 | $1.16 | — | — |
Silo Pharma book value per share trends
Over the last five fiscal years, Silo Pharma's book value per share decreased from $11.28 to $7.10, a change of -$4.18. The latest reported quarter, Q2 2026, shows $4.33.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Silo Pharma source filings ↗